Inocras
Unlock the potential of a Whole Genome Sequencing Test with Inocras. Transforming diagnosis and treatment for cancer and rare diseases.
$31M Series B+ ·
Led by AimedBio · Source: fundraisingfox.com
Funding history ↓Signals
Inocras | 979 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
- Series B+ · $31M
AAimedBio (lead),
DDSC Investment,
DDt& Investment,
DDunamu & Partners,
IIMM Investment,
KKorea Investment & Securities,
Lloftyrock investment,
NNational Diversified Sales,
SShinhan Investment,
WWoori Investment Bank
Source: fundraisingfox.com - X account created
- Website created
Founders and team
YS
Young Seok Ju Co-founder, Director of Genome Insight Institute, M.D., Ph.Dsource: inocras.comJS
Jeong Seok Lee Co-founder, Chief Innovation Officer, M.D., Ph.Dsource: inocras.comJS
Jehee Suh CEO
Investors
AAimedBiolead investor
DDSC Investment
DDt& Investment
DDunamu & Partners
IIMM Investment
KKorea Investment & Securities
Lloftyrock investment
NNational Diversified Sales
SShinhan Investment
WWoori Investment Bank
Companies like Inocras
VVariantyx$36M Series B+ · Apr 2024
OOutrun TherapeuticsSeed · Apr 2024
OOrchidSeedAAllStripes$50M Series B+ · Aug 2021
PPersonal Genome DiagnosticsSeries B+ · Nov 2025
WWobble Genomics$1.66M Seed · Sep 2021
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/inocras (get a free API key).